Lhasa Limited shared knowledge shared progress
Loading...

Publications

Jump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
TitlePublishedTypeProducts
2019 Pharmaceutical Industry and Regulators Symposium Recording - Day 1, Part 1August 2019
Aiding and standardising expert review under ICH M7March 2020pdf file
Aiding and standardising expert review under ICH M7 - RecordingMarch 2020
Beyond Mutagenicity: Supporting Toxicity Assessments For Other EndpointsJanuary 2020pdf fileDerek Nexus
Carcinogenicity Adverse Outcome PathwaysJanuary 2020pdf fileDerek NexusKaptisVitic Nexus
Comparing and combining in silico outcomes and in vitro mechanism-based assays to predict genotoxicityMarch 2020pdf fileDerek NexusVitic Nexus
Developing an adverse outcome pathway framework for carcinogenicity from alerts in an expert rule-based systemSeptember 2018pdf fileDerek Nexus
Developing an adverse outcome pathway framework for carcinogenicity from alerts in an expert rule-based system.December 2018Derek Nexus
Development Of A Network Of Adverse Outcome Pathways (AOPs) For CarcinogenicitySeptember 2018pdf fileVitic NexusDerek NexusSarah Nexus
Development of an Adverse Outcome Pathway (AOP) Network for Carcinogenicity Using Expert-Derived (Q)SAR Knowledge. PosterMarch 2019pdf fileDerek Nexus
Drawing Conventions.pdfNovember 2016pdf fileDerek Nexus
Evaluation Of A Statistics-based Ames Mutagenicity QSAR Model And Interpretation Of The Results ObtainedDecember 2015Sarah Nexus
Evaluation Of The Statistics-Based Ames Mutagenicity Model Sarah Nexus And Interpretation Of The Results ObtainedApril 2016Sarah Nexus
Extrapolation of in vitro mutagenicity alerts to the in vivo endpoint in Derek NexusAugust 2017pdf fileDerek Nexus
Extrapolation of in vitro structural alerts for mutagenicity to the in vivo endpointOctober 2018Derek Nexus
Future Developments AOP Networks And Predicting Secondary PharmacologyJanuary 2020pdf fileEffirisKaptis
How Sarah Nexus PredictsMarch 2014Sarah Nexus
Important considerations for the validation of QSAR models for in vitro mutagenicityNovember 2018Derek NexusSarah NexusVitic Nexus
Important Considerations When Building Statistical-based Mutagenicity Models.pdfNovember 2015pdf fileSarah Nexus
Improvement of quantitative structure–activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge ProjectOctober 2018Derek NexusSarah Nexus
Improving Chemical Space Coverage of an In Silico Prediction System by Targeted Inclusion of Fragments Absent from the Training SetSeptember 2017pdf fileIntermediatesSarah NexusVitic Nexus
In Silico Predictions For GenotoxicityOctober 2018pdf fileDerek NexusSarah Nexus
Leveraging Strain Information In Sarah Nexus PredictionsMarch 2018pdf fileSarah Nexus
Modelling Simple Toxicity Endpoints: Alerts, (Q)SARs and BeyondMay 2019Derek NexusMeteor NexusSarah NexusVitic Nexus
Sarah Nexus: The Statistical System for ICH M7November 2017pdf fileSarah Nexus

© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.